A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study). Fecha: Miércoles 31 de octubre de 2018
A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study) Authors: Castellsague J1, Kuiper JG2, Pottegård A3, Anveden Berglind I4, Dedman D5, Gutierrez L1, Calingaert B6, van Herk-Sukel MP2, Hallas J3, Sundström A4, Gallagher AM5, Kaye JA7, Pardo C8, Rothman KJ7, Perez-Gutthann S1. 1 Department of Epidemiology, RTI Health Solutions, Barcelona, Spain. 2 Department Research, PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands. 3 Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark. 4 Centre for Pharmacoepidemiology, Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 5 Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK. 6 Department Epidemiology, RTI Health Solu...